<DOC>
	<DOCNO>NCT02019849</DOCNO>
	<brief_summary>Twelve month follow-up implant survival clinical radiological follow-up Plasmafit® Cup .</brief_summary>
	<brief_title>Post Market Clinical Follow-Up Plasmafit® Cup</brief_title>
	<detailed_description />
	<criteria>Minimum age 18 year Indication cementless total hip arthroplasty Patient consent study participation Physical mental willingness participate clinical radiological followup Patient available followup Increased anesthetic risk accord `` American Society Anesthesiology '' : ASA IV Tumor Alcohol drug abuse Permanent cortisone therapy Clinically relevant infection Pregnancy plan pregnancy Prior intervention like osteotomy , fracture treatment prior THA concern hip Acute fracture concern hip Patients need cement hip arthroplasty</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>THA , Plasmafit®</keyword>
</DOC>